Otofarma SpA (MIL:OTO) Notes Receivable: €0.00 Mil (As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.80
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Notes Receivable?

Otofarma SpA MIL:OTO -0.71% 16 Notes Receivable is €0.00 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Otofarma SpA's Notes Receivable for the quarter that ended in Dec. 2024 was €0.00 Mil.

Otofarma SpA Notes Receivable Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Notes Receivable Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Notes Receivable
0.00 0.00

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Notes Receivable 0.00 0.00
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of €0.00 Mil mean?
Otofarma SpA (MIL:OTO) has a Notes Receivable of €0.00 Mil as of Dec. 2024. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's Notes Receivable too high?
Otofarma SpA's current Notes Receivable is €0.00 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Notes Receivable compare to ABT and SYK?
Otofarma SpA's Notes Receivable of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current Notes Receivable is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Notes Receivable of €0.00 Mil. The current Notes Receivable is €0.00 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Notes Receivable is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.80
Price